Clinical Trial Update: IVIG Trial for the Treatment of Bronchopulmonary Dysplasia [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating intravenous immunoglobulin for treatment of bronchopulmonary dysplasia is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• IVIG (intravenous immunoglobulin)

Snippet

Sponsor: International Peace Maternity and Child Health Hospital | Conditions: Bronchopulmonary Dysplasia | Phase 2 | Status: RECRUITING